EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan

Targeted oncology

Volumn 9, Issue 3, 2014, Pages 205-214

  Loupakis, Fotios ^a   Cremolini, Chiara ^a   Fioravanti, Anna ^a   Orlandi, Paola ^a   Salvatore, Lisa ^a   Masi, Gianluca ^a   Schirripa, Marta ^a   Di Desidero, Teresa ^a   Antoniotti, Carlotta ^a   Canu, Bastianina ^a   Faviana, Pinuccia ^a   Sensi, Elisa ^a   Lupi, Cristiana ^a   Fontanini, Gabriella ^a   Basolo, Fulvio ^a   Di Paolo, Antonello ^a   Danesi, Romano ^a   Falcone, Alfredo ^a   Bocci, Guido ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; B RAF KINASE; BRAF PROTEIN, HUMAN; CAMPTOTHECIN; CETUXIMAB; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; IRINOTECAN; KRAS PROTEIN, HUMAN; LIGAND; MONOCLONAL ANTIBODY; ONCOPROTEIN; RAS PROTEIN; TUMOR MARKER;

ADULT; AGED; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; BLOOD; COLORECTAL NEOPLASMS; DISEASE FREE SURVIVAL; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIGANDS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 84929939400     PISSN: None     EISSN: 1776260X     Source Type: Journal    
DOI: 10.1007/s11523-013-0284-7     Document Type: Article

References (0)